• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Isr Med Assoc J . The First Fatal Post-COVID-19 Adult Patient with Multi-System Inflammatory Syndrome in Israel

tetano

Editor, Senior Moderator
Isr Med Assoc J


. 2021 Apr;23(4):212-213.

The First Fatal Post-COVID-19 Adult Patient with Multi-System Inflammatory Syndrome in Israel


Michal A Julius[SUP] 1 2 [/SUP], Dror Cantrell[SUP] 1 2 [/SUP], Saleh Sharif[SUP] 1 2 [/SUP], Dana Zelnik Yovel[SUP] 1 2 [/SUP], Micha J Rapoport[SUP] 1 2 [/SUP]



Affiliations
  • PMID: 33899351

Abstract

Coronavirus disease-2019 (COVID-19) is recognized as a respiratory illness, which includes pulmonary consolidations, hypoxemic states, and hypercoagulopathic tendencies with a broad clinical severity. Recently, more reports have described post-infection manifestations. These include multi-system inflammatory syndrome in children (MIS-C) with more than 400 cases published since the start of the coronavirus disease pandemic. In October 2020, the U.S. Centers for Disease Control and Prevention (CDC) published 27 cases [1] describing the new multi-system inflammatory syndrome in adults (MIS-A). Nine of the cases were reported directly to the CDC, 7 from published case reports and another 11 patients found in three distinct case series.
 
Back
Top Bottom